Staffing shortages lead ECRI’s annual list of patient safety concerns
The lack of workers is actively jeopardizing patient safety with many patients waiting longer for care, even in life-threatening emergencies, according to the report.
Sutter Health defeats antitrust challenge in jury trial
The federal jury in a class action suit rejected allegations that the California hospital system drove up healthcare costs in its markets through anti-competitive practices.
Grassley pushes for PBM probe
The senator wants FTC commissioners to come up with a more targeted focus for the study and suggested narrowing a review to the impact on consumers and their out of pocket costs.
An integrated platform for intelligent care management services
Integrated care driven by analytics and digital technology is a key focus of next-generation care management programs.
6 major regional health systems form alliance to share staffing resources
Advent Health, Atrium Health, Henry Ford Health System, Intermountain Healthcare, Northwell Health and OhioHealth will participate in reciprocal staffing arrangements.
5 can’t-miss HIMSS22 panels
For those with boots on the ground in Orlando next week, here are panels you won’t want to miss, touching on some of the hottest topics in healthcare today from health equity to cybersecurity.
FDA warns of cyber vulnerabilities in medical device software components
An agency alert warned that flaws in PTC’s Axeda agent and desktop server, used in devices from several manufacturers, could allow an unauthorized attacker to take full control of the host operating system.
Providence operating loss more than doubled in 2021 as nurse shortage spurred higher labor costs
Providers are seeing expenses tied to salaries and benefits accelerate due to staffing shortages exacerbated by COVID-19.
Anthem plans to change name to Elevance
It’s the second name change for Anthem in the past decade. Prior to 2014, the company was known as WellPoint.
Akili plans to go public as it prepares to market video game treatment
“We’ve proven that foundation and now it’s time to run and scale,” CEO Eddie Martucci told MedTech Dive. The company is going public through a $1 billion SPAC, rather than a traditional IPO, expected to close in mid-2022.